Agilent Technologies, Inc.
Agilent Technologies, Inc.
Your view on A
Overview
What the company does, where it operates, and who runs it.
About Agilent Technologies, Inc.
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Padraig McDonnell
- Headquarters
- 5301 Stevens Creek Boulevard, Santa Clara, CA, US
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Padraig McDonnell
- Headquarters
- 5301 Stevens Creek Boulevard, Santa Clara, CA, US
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide.
It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics.
The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services.
The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
Fair value for Agilent Technologies, Inc. from FRC's valuation model, read against the market price. A last traded at $176.95, 35.0× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Agilent Technologies, Inc.. Starting points for Agilent Technologies, Inc.: P/E 35.0, EPS $5.11, beta 1.24 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Agilent Technologies, Inc.. Agilent Technologies, Inc. paid $1.02 per share over the last year — a 0.6% yield at the current $176.95 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Agilent Technologies, Inc.. Trailing twelve-month EPS for Agilent Technologies, Inc. stands at $5.11. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
1-Year Price Target
Low
$150.00
Median
$177.50
High
$195.00
Average target · 1 new target in the last month, average $190.00
Analyst Ratings
- Strong Buy1
- Buy32
- Hold7
- Sell1
- Strong Sell0
Earnings Estimate
| EPS | Current QtrOct 2026 | Next QtrJan 2027 | Current YearFY Oct 2026 | Next YearFY Oct 2027 |
|---|---|---|---|---|
| Avg. estimate | $1.73 | $1.50 | $6.20 | $6.70 |
| Low estimate | $1.71 | $1.47 | $6.19 | $6.50 |
| High estimate | $1.74 | $1.52 | $6.43 | $6.96 |
| No. of analysts | 11 | 6 | 12 | 12 |
| Year-ago EPS | $1.53 | $1.07 | $4.57 | — |
| Growth | +12.9% | +39.8% | +35.7% | — |
Revenue Estimate
| Revenue | Current QtrOct 2026 | Next QtrJan 2027 | Current YearFY Oct 2026 | Next YearFY Oct 2027 |
|---|---|---|---|---|
| Avg. estimate | $1.99B | $1.92B | $7.50B | $7.99B |
| Low estimate | $1.98B | $1.91B | $7.49B | $7.94B |
| High estimate | $2.01B | $1.94B | $7.71B | $8.02B |
| No. of analysts | 10 | 5 | 15 | 15 |
| Year-ago revenue | $1.86B | $1.80B | $6.95B | — |
| Growth | +6.9% | +7.1% | +7.9% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 12, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Agilent Technologies, Inc.. Agilent Technologies, Inc. has reported as a listed company since 1999. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Agilent Technologies, Inc. valued side by side against its closest peers. Agilent Technologies, Inc. is measured against Medical - Diagnostics & Research peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Agilent Technologies, Inc., and how their positions are changing. At a $49.89B market value, institutional positions materially move Agilent Technologies, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Agilent Technologies, Inc. executives and directors. Shares of Agilent Technologies, Inc. have traded between $96.43 and $153.84 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Agilent Technologies, Inc.. Agilent Technologies, Inc. is a $49.89B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Agilent Technologies, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Agilent Technologies, Inc.. Coverage tracks Agilent Technologies, Inc. within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Agilent Technologies, Inc.